Journal article
Epigenetics in cancer: Targeting chromatin modifications
L Ellis, PW Atadja, RW Johnstone
Molecular Cancer Therapeutics | AMER ASSOC CANCER RESEARCH | Published : 2009
Abstract
Posttranslational modifications to histones affect chromatin structure and function resulting in altered gene expression and changes in cell behavior. Aberrant gene expression and altered epigenomic patterns are major features of cancer. Epigenetic changes including histone acetylation, histone methylation, and DNA methylation are now thought to play important roles in the onset and progression of cancer in numerous tumor types. Indeed dysregulated epigenetic modifications, especially in early neoplastic development, may be just as significant as genetic mutations in driving cancer development and growth. The reversal of aberrant epigenetic changes has therefore emerged as a potential strate..
View full abstractGrants
Awarded by National Health and Medical Research Council (NHMRC)
Funding Acknowledgements
Grant support: R. Johnstone is a Pfizer Australia Research Fellow and is supported by National Health and Medical Research Council (NHMRC) Program Grant 251608, the Cancer Council Victoria, the Leukaemia Foundation of Australia, the Australian Rotary Health Foundation, and the Bennelong Foundation.